NSPR— InspireMD, Inc.

Health Care$37M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
REVENUES	$9.0M+28.1%	$7.0M+13.0%	$6.2M+20.0%	$5.2M
COST OF REVENUES	$6.3M+15.0%	$5.5M+25.1%	$4.4M+8.5%	$4.1M
GROSS PROFIT	$2.6M+75.9%	$1.5M-16.7%	$1.8M+61.8%	$1.1M
Research and development	$15.0M+10.0%	$13.6M+70.8%	$8.0M+2.2%	$7.8M
Selling and marketing	$16.6M+172.7%	$6.1M+57.0%	$3.9M+5.5%	$3.7M
General and administrative	$20.7M+35.3%	$15.3M+37.8%	$11.1M+32.9%	$8.4M
Total operating expenses	$52.3M+49.3%	$35.0M+52.5%	$22.9M+15.7%	$19.8M
LOSS FROM OPERATIONS	-$49.6M-48.1%	-$33.5M-58.5%	-$21.1M-13.0%	-$18.7M
FINANCIAL INCOME, net:	$891K-42.8%	$1.6M+20.5%	$1.3M+416.8%	$250K
LOSS BEFORE TAX EXPENSES	-$48.7M-52.5%	-$31.9M-60.9%	-$19.9M-7.5%	-$18.5M
TAX EXPENSES	$63K+6.8%	$59K-9.2%	$65K+132.1%	$28K
NET LOSS	-$48.8M-52.4%	-$32.0M-60.7%	-$19.9M-7.7%	-$18.5M
NET LOSS PER SHARE - basic	-$760.00+0.0%	-$760.00+7.3%	-$820.00+65.1%	-$2350.00
NET LOSS PER SHARE - diluted	-$760.00+0.0%	-$760.00+7.3%	-$820.00+65.1%	-$2350.00
WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - basic	$64325810000.00+53.4%	$41928360000.00+72.8%	$24268181000.00+208.3%	$7871814000.00
WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - diluted	$64325810000.00+53.4%	$41928360000.00+72.8%	$24268181000.00+208.3%	$7871814000.00

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 14 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.